Top Wall Street analysts have recently adjusted their outlooks on several prominent companies, including Blackstone, Virpax Pharmaceuticals, Daqo New Energy, and FactSet Research Systems. These changes involve both downgrades and price target adjustments, offering insights into the current market sentiment and potential investment strategies.